The Gut Microbiome’s Connection to Parkinson’s Disease
- Kristi Riker
- Jul 20
- 5 min read
What is the Gut Microbiome?
The gut microbiome is the community of trillions of microorganisms (bacteria, fungi, viruses) that live in the digestive tract. These microbes are essential for digestion, nutrient absorption, the immune system, and creating compounds that influence the brain. While the gut microbiome is essential to human life, when it becomes unbalanced, it can promote inflammation and contribute to disease. While a healthy gut microbiome is essential for overall health, an imbalance in these microorganisms can promote inflammation and contribute to disease.

The Gut-Brain Connection
The gut and brain constantly communicate through what is called the gut-brain axis. This is a two-way communication system between the digestive system and the brain. Although the gut and brain are anatomically separated, gut microbes send signals to the brain through several pathways, including the immune system, the vagus nerve, the bloodstream, and hormones. At the same time, the brain can influence the gut by changing digestion, gut movement, and the gut environment.

Gut-Brain Pathways:
Vagus nerve - the longest cranial nerve; connects the brain to the intestines and carries information in both directions. Specialized cells in the gut detect changes in nutrients and microbial activity, then relay these signals to the vagus nerve. In response, the brain can adjust digestion, appetite, gut movement, and even mood.
Immune system: gut microbes regulate immune responses and inflammation, which can influence brain health. When the microbiome is disrupted, harmful bacteria may promote chronic, low-grade inflammation, which influences the brain.
Bloodstream: gut bacteria break down food and release metabolites into the bloodstream which travel to the brain. In a healthy microbiome, beneficial metabolites such as butyrate help regulate immune function. However, when the microbiome is disrupted, harmful molecules can also enter the bloodstream, potentially promoting inflammation and altering gut–brain communication.
Hormones: the gut regulates and produces hormones that travel through the bloodstream, carrying signals between the gut and the brain. These hormones help regulate hunger, digestion, blood sugar, and the body's response to stress.
How is This Connected to PD?
One large study compared gut microbiome data of individuals with and without Parkinson’s disease. Despite differences in diet and geography, the researchers identified several consistent microbiome changes associated with Parkinson's.

The study found that people with Parkinson's had:
Lower levels of beneficial bacteria (particularly Faecalibacterium prausnitz
ii and Roseburia intestinalis), which produce the short-chain fatty acid butyrate that helps maintain the intestinal barrier and reduce inflammation.
Higher levels of the bacteria Akkermansia muciniphila. While this bacteria can be beneficial, its increased abundance in Parkinson's may contribute to thinning of the gut's mucus barrier and increased intestinal permeability.
Fewer bacterial genes involved in producing riboflavin (vitamin B2) and biotin (vitamin B7) which play large roles in energy production, mitochondrial function, antioxidant defenses, and nervous system health.
Together, these changes suggest that the microbiome in Parkinson's may be less able to support gut barrier function, regulate inflammation, and maintain normal gut health. It’s important to note these differences are associated with Parkinson's disease but do not prove they cause it.
How Does this Affect the Brain?
Researchers have found that the gut microbiome influences the activity of glial cells—especially microglia and astrocytes—which help protect and support neurons. When the microbiome becomes imbalanced (dysbiosis), these cells may become overactive, promoting chronic neuroinflammation that is linked to Parkinson's and other neurodegenerative diseases. Neuroinflammation is thought to accelerate the loss of dopamine-producing neurons and contribute to disease progression.
How it works:
In Parkinson's disease, abnormal clumps of the protein α-synuclein accumulate in the brain. These protein aggregates activate microglia, the brain's immune cells. Once activated, microglia release inflammatory molecules (cytokines), reactive oxygen species, and other substances that can damage nearby neurons. As neurons are damaged, they release additional signals that activate more microglia, creating a cycle of ongoing inflammation and neuronal injury.
Why Does this Matter?
Scientists are investigating whether reducing inflammation through diet, microbiome-targeted therapies, or drugs that modulate immune activity could help slow disease progression.
Observational studies consistently find that people who follow a Mediterranean-style diet or other plant-rich, high-fiber diets tend to have a lower risk of developing Parkinson's disease and, in some studies, milder symptoms or slower clinical progression. However, these studies cannot prove that diet itself slows the disease because they cannot rule out other lifestyle factors.

Microbiome-targeted therapies
Prebiotics and high-fiber diets: These diets increase butyrate-producing bacteria and improve gut health. Though, long-term studies demonstrating beneficial effects on Parkinson's progression are lacking.
Foods that support a healthy microbiome:
Fruits and vegetables
Whole grains
Beans and legumes
Yogurt and other fermented foods
Fiber and water
Foods that cause an imbalanced microbiome
Highly processed foods
Excess sugar
Probiotics: Several randomized clinical trials have shown that probiotics can improve constipation, one of the most common non-motor symptoms of Parkinson's disease. Some studies also report modest improvements in inflammatory markers, but there is no evidence that probiotics slow disease progression.
Fecal microbiota transplantation (FMT): Early pilot studies suggest FMT is feasible and may improve gastrointestinal symptoms, but it remains experimental, and there is no proof that it alters the course of Parkinson's disease.
Anti-inflammatory drugs: have shown promise in laboratory and animal studies, but clinical trials in people with Parkinson's have been inconclusive. Researchers are now focusing on therapies that target specific immune pathways rather than broadly suppressing inflammation.
Sample 3-Day Gut-Friendly Meal Plan
Day | Breakfast | Snack | Lunch | Snack | Dinner |
Day 1 | Berry Overnight Oats: rolled oats, plain kefir. blueberries, raspberries, chia seeds, walnuts, and cinnamon | Apple w/ natural almond butter | Mediterranean Chickpea Salad with chickpeas, mixed greens, cucumber, tomatoes, red onion, bell peppers, olive oil, lemon dressing, and whole-grain pita | Plain yogurt with ground flaxseed | Baked salmon, roasted broccoli, quinoa, mixed green salad with olive oil vinaigrette |
Day 2 | Greek Yogurt Parfait with strawberries, kiwi, homemade granola, and pumpkin seeds | Pear & handful of walnuts | Lentil Vegetable Soup with carrots, celery, spinach, and tomatoes, served with whole-grain bread and a side salad | Carrots with hummus | Tofu vegetable stir-fry w/ broccoli, mushrooms, bok choy, brown rice, kimchi |
Day 3 | Avocado Toast on whole-grain bread w/ tomato slices & hemp seeds; side of an orange and plain kefir | Mixed berries w/ pistachios | Mediterranean Grain Bowl with farro or quinoa, white beans, roasted Brussels sprouts, sweet potato, kale, and olive oil-lemon dressing | Cottage cheese with a peach | Baked cod, roasted asparagus, barley, and a spinach salad with walnuts and blueberries |
Foods That Feed Beneficial Gut Bacteria
High-Fiber Foods (Prebiotics)
Oats
Barley
Beans
Lentils
Chickpeas
Garlic
Onions
Asparagus
Artichokes
Apples
Bananas
Berries
Fermented Foods (Probiotics)
Kefir
Plain yogurt with live cultures
Kimchi
Sauerkraut
Miso
Tempeh
Foods Rich in Polyphenols
Blueberries
Strawberries
Raspberries
Green tea
Olive oil
Cocoa
Walnuts
Healthy Fats
Olive oil
Salmon
Sardines
Walnuts
Flaxseed
Chia seeds
Looking to the Future
Although microbiome-based therapies are still experimental, they have the potential to transform Parkinson's care. Future treatment may combine traditional medications with personalized nutrition and targeted microbiome interventions to support gut health, improve symptom management, enhance medication response, and potentially influence disease progression. Larger clinical trials are needed to determine which approaches are safe and effective.
Resources
Aburto, M.R., Cryan, J.F. Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota–gut–brain axis. Nat Rev Gastroenterol Hepatol 21, 222–247 (2024). https://doi.org/10.1038/s41575-023-00890-0
Kwon, D., Zhang, K., Paul, K.C. et al. Diet and the gut microbiome in patients with Parkinson’s disease. npj Parkinsons Dis. 10, 89 (2024). https://doi.org/10.1038/s41531-024-00681-7
Loh, J.S., Mak, W.Q., Tan, L.K.S. et al. Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases. Sig Transduct Target Ther 9, 37 (2024). https://doi.org/10.1038/s41392-024-01743-1
Menozzi, E., Schapira, A.H.V. The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications. CNS Drugs 38, 315–331 (2024). https://doi.org/10.1007/s40263-024-01073-4
Schneider, E., O’Riordan, K.J., Clarke, G. et al. Feeding gut microbes to nourish the brain: unravelling the diet–microbiota–gut–brain axis. Nat Metab 6, 1454–1478 (2024). https://doi.org/10.1038/s42255-024-01108-6



Comments